BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 34967811)

  • 1. Risk factors for cervical cancer among distinct populations in low-resource countries: feasibility of cervical cancer screen-and-treat program on ukerewe island of lake victoria, Tanzania.
    Hari AY; Bernstein M; Temko J; Brabender DE; Shen A; Tewari KS
    Curr Opin Obstet Gynecol; 2022 Feb; 34(1):20-27. PubMed ID: 34967811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual inspection with acetic acid screening for cervical cancer among women receiving anti-retroviral therapy for human immunodeficiency virus infection in northern Tanzania.
    Chinn JO; Runge AS; Dinicu AI; Chang J; Maher JA; Crawford EW; Naaseh A; Cooper EC; Zezoff DC; White KM; Lucas AN; Bera KR; Bernstein M; Hari A; Ziogas A; Tewari SE; Pearre DC; Tewari KS
    J Obstet Gynaecol Res; 2021 Dec; 47(12):4365-4370. PubMed ID: 34614540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Cervical Cancer Screening Programs in Côte d'Ivoire, Guyana, and Tanzania: Effect of HIV Status.
    Anderson J; Wysong M; Estep D; Besana G; Kibwana S; Varallo J; Sun K; Lu E
    PLoS One; 2015; 10(9):e0139242. PubMed ID: 26405784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cancer screening and treatment, HIV infection, and age: Program implementation in seven regions of Namibia.
    Korn AK; Muzingwani L; O'Bryan G; Ensminger A; Boylan AD; Kafidi EL; Kashali M; Ashipala L; Nitschke AM; Dziuban EJ; Forster N; Eckert LO; O'Malley G
    PLoS One; 2022; 17(2):e0263920. PubMed ID: 35171941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of thermo-coagulation as an alternative treatment modality in a 'screen-and-treat' programme of cervical screening in rural Malawi.
    Campbell C; Kafwafwa S; Brown H; Walker G; Madetsa B; Deeny M; Kabota B; Morton D; Ter Haar R; Grant L; Cubie HA
    Int J Cancer; 2016 Aug; 139(4):908-15. PubMed ID: 27006131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes from 8 years of cervical cancer screening at a rural screen-and-treat site in northern Tanzania.
    Maillie L; Yussuph A; Chirangi B; Schroeder K
    Int J Gynaecol Obstet; 2023 Feb; 160(2):604-611. PubMed ID: 36052864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
    Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
    PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical cancer screening in a low-resource setting: a pilot study on an HPV-based screen-and-treat approach.
    Kunckler M; Schumacher F; Kenfack B; Catarino R; Viviano M; Tincho E; Tebeu PM; Temogne L; Vassilakos P; Petignat P
    Cancer Med; 2017 Jul; 6(7):1752-1761. PubMed ID: 28580596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer screening - The challenges of complete pathways of care in low-income countries: Focus on Malawi.
    Cubie HA; Campbell C
    Womens Health (Lond); 2020; 16():1745506520914804. PubMed ID: 32364058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
    Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
    Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
    Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
    Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screen-and-treat approach to cervical cancer prevention using visual inspection with acetic acid and cryotherapy: experiences, perceptions, and beliefs from demonstration projects in Peru, Uganda, and Vietnam.
    Paul P; Winkler JL; Bartolini RM; Penny ME; Huong TT; Nga le T; Kumakech E; Mugisha E; Jeronimo J
    Oncologist; 2013; 18(12):1278-84. PubMed ID: 24217554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
    Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
    Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "The best thing is that you are doing it for yourself" - perspectives on acceptability and feasibility of HPV self-sampling among cervical cancer screening clients in Tanzania: a qualitative pilot study.
    Bakiewicz A; Rasch V; Mwaiselage J; Linde DS
    BMC Womens Health; 2020 Mar; 20(1):65. PubMed ID: 32234028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for VIA positivity and determinants of screening attendances in Dar es Salaam, Tanzania.
    Kahesa C; Kjaer SK; Ngoma T; Mwaiselage J; Dartell M; Iftner T; Rasch V
    BMC Public Health; 2012 Dec; 12():1055. PubMed ID: 23216752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downstaging of cervical cancer in Tanzania over a 16-year period.
    Mattick LJ; Ochs-Balcom HM; Mwaiselage J; Kahesa C; Gard AC; Shalan F; Soliman AS
    Cancer Causes Control; 2021 Apr; 32(4):401-407. PubMed ID: 33559768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV-based cervical cancer screening in Nicaragua: from testing to treatment.
    Holme F; Maldonado F; Martinez-Granera OB; Rodriguez JM; Almendarez J; Slavkovsky R; Bansil P; Thomson KA; Jeronimo J; de Sanjose S
    BMC Public Health; 2020 Apr; 20(1):495. PubMed ID: 32295562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of a human papillomavirus screen-and-treat model in Mwanza, Tanzania: training local healthcare workers for sustainable impact.
    Bernstein M; Hari A; Aggarwal S; Lee D; Farfel A; Patel P; Raman K; Raja S; Fenning R; Lieber M; Minteer W; Denny S; Ries M
    Int Health; 2018 May; 10(3):197-201. PubMed ID: 29579207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a single-visit approach to cervical cancer screening and treatment in Guyana: feasibility, effectiveness and lessons learned.
    Martin CE; Tergas AI; Wysong M; Reinsel M; Estep D; Varallo J
    J Obstet Gynaecol Res; 2014 Jun; 40(6):1707-16. PubMed ID: 24888938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tanzanian women´s knowledge about Cervical Cancer and HPV and their prevalence of positive VIA cervical screening results. Data from a Prevention and Awareness Campaign in Northern Tanzania, 2017 - 2019.
    Henke A; Kluge U; Borde T; Mchome B; Serventi F; Henke O
    Glob Health Action; 2021 Jan; 14(1):1852780. PubMed ID: 33371824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.